Syphilis Testing Market to Signify Strong Growth by 2023-2030

During the projected period (2023-2030), it is anticipated that the global syphilis testing market will expand at a CAGR of 6.2%. Syphilis tests is used to diagnose and find bacteria-specific antibodies in a patient’s blood. Syphilis can cause a number of issues, including death from illness and infertility in both sexes, ectopic pregnancy, and cervical cancer in females. The World Health Organization (WHO) estimates that 7.1 million adults between the ages of 15 and 49 globally contracted syphilis. Syphilis cases among males who have intercourse with other men are significantly rising in those nations that routinely monitor the disease, including congenital syphilis. The rising prevalence of STD and technological advances are the primary factors propelling the syphilis test market’s expansion. The availability of testing equipment, the quick development of diagnostic instruments, and enhanced healthcare facilities are further drivers anticipated to spur market expansion throughout the projection period. The global market for syphilis testing has grown due to rise in diseases like syphilis and other sexually transmitted illnesses. For instance, in April 2023, according to a report from the Centers for Disease Control and Prevention (CDC), Congenital syphilis cases climbed by 32% from 2,148 to more than 2,800, resulting in 220 stillbirths and infant deaths. These cases happen when a baby is born with the condition after the mother transmitted it to her during pregnancy.

The increasing adoption of strategic initiatives by numerous industry-important players is another element promoting market expansion. Syphilis testing kits and complementary service portfolios are being developed with an emphasis on technology developments by the key companies in the market. The important market players in the syphilis testing market include Roche Diagnostics, Hologic, Inc., Becton Dickinson & Company, Abbott laboratories, BioMerieux, Astam Dignostic, Cepheid Inc., Affymetrix, Inc., and Diasorin. For Instance, In February 2023 Mylab discovery Solutions, a company based in Pune, is introducing three new rapid kits for the early and quick diagnosis of STIs like the human immunodeficiency virus (HIV), hepatitis C Virus (HCV), and syphilis. According to predictions from the World Health Organization (WHO), there will be 1 million new cases of STIs each day globally, making these infections a serious health threat.

To Request a Sample of our Report on Syphilis Testing Market:  https://www.omrglobal.com/request-sample/syphilis-testing-market

Market Coverage

  • The market number available for – 2022-2030
  • Base year- 2022
  • Forecast period- 2023-2030

Segment Covered- 

  • By Type
  • By Location of Testing
  • By Technology

Regions Covered-

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
  • Competitive Landscape- includes Abbott laboratories, Becton Dickinson and company, Bio-Rad laboratories Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., and others.

A full Report of Syphilis Testing Market is Available @  https://www.omrglobal.com/industry-reports/syphilis-testing-market

Syphilis Testing Market Report Segment

By Type

  • Primary and secondary syphilis
  • Latent and tertiary syphilis

By Location of Testing

  • Laboratory Testing
  • Point-of-Care (POC) testing

By Technology

  • Clinical Laboratory Improvement Amendments (CLIA)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Nucleic Acid Amplification Test (NAAT)
  • Others

By End-User

  • Hospitals
  • Diagnostic labs
  • Home care

Syphilis Testing Market Report Segment by Region

North America                                                                                                           

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe

Asia-Pacific

  • India
  • China
  • Japan
  • South Korea
  • Rest of APAC

Rest of the World

  • Latin America
  • Middle East and Africa

Company Profiles

  • Astam Dignostic
  • Beckman Coulter
  • bioLytical laboratories Inc.
  • BioMerieux SA
  • Cepheid Inc.
  • Danaher corp.
  • Diasorin S.P.A
  • DRG International Inc. (BioCheck Inc.)
  • Hoffmann-La Roche AG
  • Fujirebio
  • Hologoic Inc
  • Omega diagnostics Group PLC
  • Shenzhen new industries Biomedical Engineering Co., Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

Reasons to buy from us –

  1. We cover more than 15 major industries, further segmented into more than 90 sectors.
  2. More than 120 countries are for analysis.
  3. Over 100+ paid data sources mined for investigation.
  4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/syphilis-testing-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404